Shares of Medtronic PLC MDT, +0.40% were up 0.36% in trading on Thursday. The Food and Drug Administration said Wednesday taht Medtronic had issued a recall of its MiniMed 600 Series Insulin Pumps after reports of 2,175 injuries and one death. The regulator said it is the most serious type of recall. A missing piece can cause incorrect dosing, which can lead to hypoglycemia or hyperglycemia in the Type 1 diabetes patients who use the device. Medtronic first notified affected patients of the recall in November. Medtronic’s stock has gained 29% over the past year, while the S&P 500 SPX, +0.10% is up 23%.